Global Acute Myeloid Leukemia Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: GB1D2A492B51EN
QYResearch

Abstracts

This report focuses on the global Acute Myeloid Leukemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Acute Myeloid Leukemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Ambit Biosciences Corporation
• Celgene Corporation
• Cephalon
• Clavis Pharma
• Eisai
• Genzyme Corporation
• Sunesis Pharmaceuticals
• ...

Market segment by Type, the product can be split into

• DC regimen
• AVD Regimen
• VCD regimen

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Acute Myeloid Leukemia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Acute Myeloid Leukemia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Acute Myeloid Leukemia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Acute Myeloid Leukemia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 DC regimen
  1.4.3 AVD Regimen
  1.4.4 VCD regimen
1.5 Market by Application
  1.5.1 Global Acute Myeloid Leukemia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Acute Myeloid Leukemia Treatment Market Perspective (2015-2026)
2.2 Acute Myeloid Leukemia Treatment Growth Trends by Regions
  2.2.1 Acute Myeloid Leukemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Acute Myeloid Leukemia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Acute Myeloid Leukemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Acute Myeloid Leukemia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Acute Myeloid Leukemia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Acute Myeloid Leukemia Treatment Players by Market Size
  3.1.1 Global Top Acute Myeloid Leukemia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Acute Myeloid Leukemia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio
  3.2.1 Global Acute Myeloid Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Treatment Revenue in 2019
3.3 Acute Myeloid Leukemia Treatment Key Players Head office and Area Served
3.4 Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
3.5 Date of Enter into Acute Myeloid Leukemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Acute Myeloid Leukemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Type (2021-2026)

5 ACUTE MYELOID LEUKEMIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)
5.2 Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Acute Myeloid Leukemia Treatment Market Size (2015-2020)
6.2 Acute Myeloid Leukemia Treatment Key Players in North America (2019-2020)
6.3 North America Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
6.4 North America Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Acute Myeloid Leukemia Treatment Market Size (2015-2020)
7.2 Acute Myeloid Leukemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
7.4 Europe Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Acute Myeloid Leukemia Treatment Market Size (2015-2020)
8.2 Acute Myeloid Leukemia Treatment Key Players in China (2019-2020)
8.3 China Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
8.4 China Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Acute Myeloid Leukemia Treatment Market Size (2015-2020)
9.2 Acute Myeloid Leukemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
9.4 Japan Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Acute Myeloid Leukemia Treatment Market Size (2015-2020)
10.2 Acute Myeloid Leukemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Acute Myeloid Leukemia Treatment Market Size (2015-2020)
11.2 Acute Myeloid Leukemia Treatment Key Players in India (2019-2020)
11.3 India Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
11.4 India Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Acute Myeloid Leukemia Treatment Market Size (2015-2020)
12.2 Acute Myeloid Leukemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Ambit Biosciences Corporation
  13.1.1 Ambit Biosciences Corporation Company Details
  13.1.2 Ambit Biosciences Corporation Business Overview and Its Total Revenue
  13.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Introduction
  13.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020))
  13.1.5 Ambit Biosciences Corporation Recent Development
13.2 Celgene Corporation
  13.2.1 Celgene Corporation Company Details
  13.2.2 Celgene Corporation Business Overview and Its Total Revenue
  13.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Introduction
  13.2.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.2.5 Celgene Corporation Recent Development
13.3 Cephalon
  13.3.1 Cephalon Company Details
  13.3.2 Cephalon Business Overview and Its Total Revenue
  13.3.3 Cephalon Acute Myeloid Leukemia Treatment Introduction
  13.3.4 Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.3.5 Cephalon Recent Development
13.4 Clavis Pharma
  13.4.1 Clavis Pharma Company Details
  13.4.2 Clavis Pharma Business Overview and Its Total Revenue
  13.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Introduction
  13.4.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.4.5 Clavis Pharma Recent Development
13.5 Eisai
  13.5.1 Eisai Company Details
  13.5.2 Eisai Business Overview and Its Total Revenue
  13.5.3 Eisai Acute Myeloid Leukemia Treatment Introduction
  13.5.4 Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.5.5 Eisai Recent Development
13.6 Genzyme Corporation
  13.6.1 Genzyme Corporation Company Details
  13.6.2 Genzyme Corporation Business Overview and Its Total Revenue
  13.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Introduction
  13.6.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.6.5 Genzyme Corporation Recent Development
13.7 Sunesis Pharmaceuticals
  13.7.1 Sunesis Pharmaceuticals Company Details
  13.7.2 Sunesis Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Introduction
  13.7.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020)
  13.7.5 Sunesis Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Acute Myeloid Leukemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Acute Myeloid Leukemia Treatment Revenue
Table 3. Ranking of Global Top Acute Myeloid Leukemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Acute Myeloid Leukemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DC regimen
Table 6. Key Players of AVD Regimen
Table 7. Key Players of VCD regimen
Table 8. Global Acute Myeloid Leukemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Acute Myeloid Leukemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Acute Myeloid Leukemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2015-2020)
Table 12. Global Acute Myeloid Leukemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Acute Myeloid Leukemia Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Acute Myeloid Leukemia Treatment Players
Table 19. Global Acute Myeloid Leukemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Acute Myeloid Leukemia Treatment Market Share by Players (2015-2020)
Table 21. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2019)
Table 22. Global Acute Myeloid Leukemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Acute Myeloid Leukemia Treatment Product Solution and Service
Table 25. Date of Enter into Acute Myeloid Leukemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Acute Myeloid Leukemia Treatment Market Size Share by Type (2015-2020)
Table 29. Global Acute Myeloid Leukemia Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Acute Myeloid Leukemia Treatment Market Size Share by Application (2015-2020)
Table 31. Global Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Acute Myeloid Leukemia Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 35. North America Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 37. North America Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 41. Europe Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 43. Europe Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 47. China Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 49. China Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 53. Japan Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 55. Japan Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 59. Southeast Asia Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 65. India Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 67. India Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Acute Myeloid Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Acute Myeloid Leukemia Treatment Market Share (2019-2020)
Table 71. Central & South America Acute Myeloid Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Acute Myeloid Leukemia Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Acute Myeloid Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Acute Myeloid Leukemia Treatment Market Share by Application (2015-2020)
Table 75. Ambit Biosciences Corporation Company Details
Table 76. Ambit Biosciences Corporation Business Overview
Table 77. Ambit Biosciences Corporation Product
Table 78. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 79. Ambit Biosciences Corporation Recent Development
Table 80. Celgene Corporation Company Details
Table 81. Celgene Corporation Business Overview
Table 82. Celgene Corporation Product
Table 83. Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 84. Celgene Corporation Recent Development
Table 85. Cephalon Company Details
Table 86. Cephalon Business Overview
Table 87. Cephalon Product
Table 88. Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 89. Cephalon Recent Development
Table 90. Clavis Pharma Company Details
Table 91. Clavis Pharma Business Overview
Table 92. Clavis Pharma Product
Table 93. Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 94. Clavis Pharma Recent Development
Table 95. Eisai Company Details
Table 96. Eisai Business Overview
Table 97. Eisai Product
Table 98. Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 99. Eisai Recent Development
Table 100. Genzyme Corporation Company Details
Table 101. Genzyme Corporation Business Overview
Table 102. Genzyme Corporation Product
Table 103. Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 104. Genzyme Corporation Recent Development
Table 105. Sunesis Pharmaceuticals Company Details
Table 106. Sunesis Pharmaceuticals Business Overview
Table 107. Sunesis Pharmaceuticals Product
Table 108. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2015-2020) (Million US$)
Table 109. Sunesis Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Acute Myeloid Leukemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. DC regimen Features
Figure 3. AVD Regimen Features
Figure 4. VCD regimen Features
Figure 5. Global Acute Myeloid Leukemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Myeloid Leukemia Treatment Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Acute Myeloid Leukemia Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Acute Myeloid Leukemia Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Acute Myeloid Leukemia Treatment Market Share by Players in 2019
Figure 15. Global Top Acute Myeloid Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Treatment Revenue in 2019
Figure 17. North America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Acute Myeloid Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Ambit Biosciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 26. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 28. Cephalon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 30. Clavis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 32. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 34. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 36. Sunesis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Treatment Business (2015-2020)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed